| Patent | Date |
|---|
Treatment Of Prostate Cancer
App 20210205303 - RAJASEKHAR; Vijaykumar Reddy ; et al. | 2021-07-08 |
Treatment of prostate cancer
Grant 10,786,501 - Rajasekhar , et al. September 29, 2 | 2020-09-29 |
Treatment Of Prostate Cancer
App 20200129507 - RAJASEKHAR; Vijaykumar Reddy ; et al. | 2020-04-30 |
Treatment of prostate cancer
Grant 10,449,191 - Rajasekhar , et al. Oc | 2019-10-22 |
Treatment Of Prostate Cancer
App 20190224196 - RAJASEKHAR; Vijaykumar Reddy ; et al. | 2019-07-25 |
Modulation of atp production or content in the hypothalamus
App 20060233861 - Maclean; David B. | 2006-10-19 |
Therapy for andropause using estrogen agonists/antagonists and testosterone
App 20050288325 - MacLean, David B. | 2005-12-29 |
Methods of treatment using an EP2 selective receptor agonist
App 20050203086 - Constan, Alexander A. ; et al. | 2005-09-15 |
Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions
App 20050148625 - MacLean, David B. ; et al. | 2005-07-07 |
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
Grant 6,911,456 - MacLean , et al. June 28, 2 | 2005-06-28 |
Use of growth hormone secretagogues for treatment of physical performance decline
App 20040122062 - MacLean, David B. ; et al. | 2004-06-24 |
Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions
App 20040009994 - MacLean, David B. ; et al. | 2004-01-15 |
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
App 20030220349 - MacLean, David B. ; et al. | 2003-11-27 |
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
Grant 6,613,796 - Maclean , et al. September 2, 2 | 2003-09-02 |
Therapy for andropause using estrogen agonists / antagonists and testosterone
App 20020115676 - MacLean, David B. | 2002-08-22 |
Intermittent administration of a growth hormone secretagogue
App 20020094992 - MacLean, David B. | 2002-07-18 |
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
App 20020091121 - MacLean, David B. ; et al. | 2002-07-11 |
Use of growth hormone secretagogues for treatment of physical performance decline
App 20020028838 - MacLean, David B. ; et al. | 2002-03-07 |
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
App 20010018451 - Maclean, David B. ; et al. | 2001-08-30 |
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
Grant 6,274,618 - MacLean , et al. August 14, 2 | 2001-08-14 |
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
Grant 6,107,331 - MacLean , et al. August 22, 2 | 2000-08-22 |
Method of increasing testosterone
Grant 6,017,964 - MacLean , et al. January 25, 2 | 2000-01-25 |
Method of treating diseases and conditions with estrogen agonists and antagonists
Grant 5,889,042 - MacLean , et al. March 30, 1 | 1999-03-30 |
Combination therapy to prevent bone loss parathyroid hormone and estrogen agonists
Grant 5,861,438 - MacLean , et al. January 19, 1 | 1999-01-19 |
Inhibition of myeloperoxidase activity
Grant 5,719,190 - MacLean , et al. February 17, 1 | 1998-02-17 |
| 